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Abstract 
Aging is associated with increased onset of diseases such as type 2 diabetes (T2D) and 
cognitive impairment. Heart rate variability (HRV), a measure of autonomic function, is 
reduced in T2D and may have the potential to indicate cognitive decline in this 
population. Square-stepping exercise (SSE) is a novel cognitive exercise recently 
implemented in cognitive research, which may have the potential to improve global 
cognitive function in T2D individuals. Participants with T2D (N=25, aged ≥ 50y) and 
self-reported cognitive complaints were randomized into either an SSE intervention or a 
wait-list (WL) control group for 24-weeks. HRV parameters (time and frequency domain) 
and GCF domains were assessed at baseline and 24-weeks. No significant differences 
were found in HRV parameters between groups at baseline and 24-weeks. However, heart 
rate was significantly reduced from baseline to 24-weeks in the SSE group, p = 0.046. 
Additionally, low and high frequency power were significantly decreased from baseline 
to 24-weeks in the WL group, p = 0.05 and p = 0.043 respectively. This study elucidates 
the impact of cognitive exercise training on HRV, however, it is inconclusive as to why a 
shift towards vagal modulation was observed in both the SSE and WL groups.  
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Chapter 1 
 
1.1       Literature Review 
1.2 Epidemiology of Diabetes Mellitus 
In 2011, an estimated 366 million people around the world were diagnosed with Type 2 
diabetes (T2D), and this number is projected to rise by 51%, reaching 552 million by 
2030 (Whiting et al., 2011). The prevalence of T2D diagnosis of Canadians aged 12 years 
or older in 2014 was 6.7% overall (approximately 2.0 million people) with 5.8% reported 
in women and 7.5% in men (Diabetes, 2015). In 2006, persons aged 75 to 79 years had 
the highest prevalence of T2D for both men and women at an average of 23.4%. Recently 
however, this trend has shifted to a younger age bracket (60 to 64 years) as the “baby 
boomer” generation ages and the prevalence of obesity rises (Report from the National 
Diabetes Surveillance System, 2009). Not only is T2D a burden on quality of life and 
independence for the individual, but it is also a burden on families, caregivers and the 
healthcare systems with regards to costs and liabilities associated with aging and disease 
(Hayes et al., 2014). 
1.2.1 Types 2 Diabetes Mellitus 
Diabetes mellitus is a chronic metabolic disease that affects the way the body metabolizes 
glucose (Canadian Diabetes Association, 2008). In healthy individuals following a meal, 
carbohydrates are broken down into glucose (a form of simple sugar) and enter the blood 
stream. Insulin, a hormone produced by beta cells in the pancreas, is released into the 
blood stream to absorb glucose (Harlan, 2014) and stores it as glycogen in the liver and 
skeletal muscles. Diabetics are either unable to produce insulin, unable to produce enough 
insulin or unable to effectively use the insulin that is produced to control blood glucose 
levels (Mayo Clinic, 2014). Due to insulin resistance, diabetics experience high levels of 
blood glucose (hyperglycemia).  
There are three main types of diabetes: gestational, Type 1 and Type 2. Gestational 
diabetes is a form of diabetes that develops during pregnancy that may complicate 
pregnancy and affect the health of the baby (Harlan, 2014). Type 1 diabetes, formerly 
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known as juvenile diabetes, occurs when the body’s immune system attacks pancreatic 
beta cells resulting in the inability to produce insulin which causes hyperglycemia 
following a meal (Canadian Diabetes Association, 2008). And T2D, formally known as 
adult-onset diabetes, is the most common form, at 90-95% of cases diagnosed (Harlan, 
2014). Diagnosis of hyperglycemia and T2D is confirmed and monitored via blood 
work—i.e. glycated hemoglobin (HbA1c), fasting plasma glucose and oral glucose 
tolerance tests. T2D was originally seen in older adults, however, incidences are 
beginning to appear at younger ages due to physical inactivity and increased childhood 
obesity (Hannon et al., 2005). Over time hyperglycemia causes nerve and vasculature 
damage, leading to severe health problems such as cardiovascular disease (CVD)—i.e. 
hypertension, atherosclerosis, heart attack and stroke, kidney disease, 
retinopathy/blindness, peripheral neuropathy, autonomic dysfunction, cognitive 
impairment, reduced mobility and depression (Harlan, 2014; Matei et al., 2013). The risk 
factors associated with the development of T2D are either modifiable or non-modifiable. 
Age (> 40 years), gender (male), family history, and race (Aboriginal, Asian, African and 
Hispanic) are all non-modifiable risk factors, whereas, weight (overweight and obese), 
physical inactivity, dyslipidemia and hypertension are all modifiable risk factors (Mayo 
Clinic, 2014; Harlan, 2014). If left untreated, T2D complications can lead to death. 
Treatment prevents some complications but it does not restore normoglycemia or 
completely eliminate all adverse consequences associated with T2D (Knowler et al., 
2002).  
1.3 Aging and Cognitive Impairment in Diabetes 
Global cognitive function embodies overall cognitive function of the brain including  
executive function (planning, inhibition, task switching, maintenance and manipulation of 
information), episodic memory, reasoning, thinking, attention, language and processing 
speed (Hayes et al., 2014). Successful aging is defined by Rowe & Kahn (1997) as 
multidimensional, consisting of disease and disability avoidance, maintenance of high 
physical and cognitive function, and sustained engagement in social and productive 
activities. Poor social integration is associated with higher mortality rates in aging 
populations (Rowe & Kahn, 1997). In individuals aged 50 years and older, there is also a 
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higher prevalence of cognitive decline regardless of successful aging (Acee, 2012). 
Nonetheless, many older adults do not meet this definition of successful aging and instead 
are at risk for various diseases such as CVD, T2D and dementia (Rowe & Kahn, 1997). 
These chronic diseases are correlated with increased age and contribute to the loss of 
mobility and decrease in overall well-being. T2D is not the only chronic disorder 
expected to rise in the oncoming years. Of the other disorders related to chronological 
aging that are expected to increase significantly, dementia is the foremost (Acee, 2012). 
In Canada, it was estimated that nearly 15% (747,000) of older adults were diagnosed 
with dementia or Alzheimer’s disease in 2011. It was also predicted that unless treatments 
were implemented, this figure is expected to reach 1.4 million by 2031 (Alzheimer 
Society, 2012). The Mini-Mental State Examination (MMSE) and the Montreal Cognitive 
Assessment (MOCA) are both simple cognitive tests with a battery of questions aimed at 
screening for cognitive impairment. The MMSE is both reliable and a valid test for 
estimating the severity of cognitive impairment in individuals with dementia, delirium, 
schizophrenia or affective disorder (Folstein et al., 1975). The MOCA is highly sensitive 
in identifying individuals with subtle cognitive decline, however, it may not be significant 
enough to warrant a diagnosis of dementia (Gill et al., 2016).  
Cognitive impairment can be classified as subjective cognitive complaints, mild cognitive 
impairment (MCI), and dementia. A subjective cognitive complaint is the belief that one’s 
thinking and/or memory has gotten worse recently, and occurs frequently in the elderly. 
Longitudinal studies have identified subjective cognitive complaints as a future predictor 
of MCI and dementia (Jessen et al., 2007; Xu et al., 2010). MCI represents the transitional 
phase between normal cognitive function and dementia, although not all people with MCI 
will develop dementia (Ettorre et al., 2012; Xu et al., 2010). In a study by Xu et al (2010), 
pre-diabetes and T2D were found to accelerate the progression from MCI to dementia, as 
well as T2D increased the incidence of dementia by 50-100% when compared to people 
without diabetes (Xu et al., 2010). Dementia is a broad term encompassing many forms of 
cognitive impairment. Vascular dementia (also known as vascular cognitive impairment), 
was found to be two to three times more likely in T2D individuals than normal age-
matched individuals, and is the most prevalent of the dementias seen in this population 
(Acee, 2012). Vascular dementia is thought to be caused by small artery disease linked 
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with CVD risk factors (age, hypertension, dyslipidemia, smoking and alcoholism) and 
poor glycemic control. It is characterized by chronic reduced blood flow in the brain, 
ultimately leading to brain tissue death and dementia (Acee, 2012). Cerebral damage such 
as reduced brain volume and increased white matter hyperintensity volume lead to 
reduced cognitive performance (Gauthier et al., 2015). Decline in cognitive function is 
particularly found in executive function, processing speed and episodic memory and is 
due to structural and functional alterations in the fronto-parietal and medial temporal 
brain regions (Hayes et al., 2014).  
1.4  Cardiovascular Autonomic Function 
The autonomic nervous system (ANS) is composed of two major branches, the 
sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS), 
which work together to control involuntary functions such as heart rate (HR), blood 
pressure (BP), respiratory rate, digestion, urination and sexual arousal (Barrett et al., 
2010). The SNS is associated with energy mobilization whereas the PNS is associated 
with restorative functions. The dynamic interaction between the two systems is called 
autonomic balance and allows for environmental adaptation (Thayer et al., 2010). The 
SNS and PNS are important regulators of the cardiovascular (CV) system. Activation of 
sympathetic nerves going to the heart and blood vessels are excitatory and mediated by 
the release of epinephrine and norepinephrine. They increase myocardial contractility, 
resulting in elevated cardiac output, HR and BP. Parasympathetic activation, provided 
primarily by the vagus nerve, is mediated by acetylcholine. It provides an inhibitory 
response and opposes SNS activity resulting in decreased myocardial activity, cardiac 
output, HR and BP (Stuckey & Petrella, 2013; Task Force of the European Society of 
Cardiology, 1996).  
1.4.1 Autonomic Responses to Postural Changes 
Under resting conditions, such as a supine position, vagal activity prevails due to the 
sinus node being rich in acetylcholinesterase, resulting in rapid vagal transmission thus 
reducing HR (Task Force of the European Society of Cardiology, 1996). There is no 
influence of gravity and activation of baroreceptors is only determined by changes in BP 
mediated by respiratory movements (Michel-Chávez et al., 2015). Baroreceptors are 
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stretch receptors located in the carotid arteries and aortic arch. They respond to changes 
in BP via a control loop known as the baroreflex. The baroreflex is the most important 
short-term mechanism for BP regulation (Stuckey & Petrella, 2013). Raised BP results in 
a baroreflex-mediated increase in PNS and/or reduction in SNS activity, and vice versa 
for reduced BP. Baroreflex sensitivity (BRS) refers to the capacity of the baroreflex to 
adjust HR and vascular resistance in response to changes in BP (Stuckey & Petrella, 
2013).  
Transitional changes, such as sitting and standing invoke physical challenges imposed by 
gravity, and cause a temporary drop in BP and increase in HR, as a consequence of BRS 
activation (Michel-Chávez et al., 2015). These changes from supine to sitting and 
subsequently to standing, result in stronger SNS stimulation with corresponding vagal 
withdrawal (Hnatkova et al., 2013). In disease populations, in which sympathetic 
denervation of the blood vessels is occurring, autonomic dysfunction correlates clinically 
with postural hypotension and impaired BRS function (Michel-Chávez et al., 2015). In 
T2D, arterial stiffness prevents stretch receptors in the carotid arteries and the aorta from 
sensing subtle changes in BP, thus increasing the time it takes to activate the baroreflex. 
This delay is indicative of reduced BRS and leads to postural hypotension (Michel-
Chávez et al., 2015).  
Chemoreflexes are also important modulators of SNS activation. Peripheral 
chemoreceptors are located in the carotid arteries and respond primarily to hypoxaemia 
(low oxygen), while central chemoreceptors are located in the brainstem and respond to 
hypercapnia (high carbon dioxide). Activation of either the hypoxic or hypercapnic 
chemoreflex results in both hyperventilation and SNS activation (Kara et al., 2003). In 
healthy individuals, SNS and PNS are closely regulated to maintain autonomic balance. 
In aging and clinical populations, sympathetic and parasympathetic nerves innervating the 
heart and blood vessels become damaged leading to autonomic imbalance and 
dysfunction (Thayer et al., 2010).  
1.4.2 Autonomic Dysfunction in Type 2 Diabetes 
Autonomic imbalance occurs when one branch of the ANS dominates over the other. It is 
associated with a lack of dynamic flexibility and reduced health (Thayer et al., 2010), and 
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progresses to autonomic dysfunction. Autonomic imbalance typically occurs when the 
SNS is hyperactive and the PNS is hypoactive, causing a predominance of sympathetic 
activity (Michel-Chávez et al., 2015). Hypoactivity may be a result of denervation to the 
vagus nerve caused by chronic hyperglycemia (Brownlee, 2005) which is responsible for 
nearly 75% of PNS activity (Balcıoğlu & Müderrisoğlu, 2015). PNS nerve fibers may 
become damaged earlier with autonomic dysfunction, however, over time SNS nerve 
fibers are also affected (Vinik & Ziegler, 2007). When the SNS dominates for long 
periods of time, energy demands on the system become excessive, and ultimately cannot 
be met, eventually leading to neuronal death (Thayer et al., 2010). In T2D, cardiac 
autonomic neuropathy (CAN) is a form of autonomic dysfunction and causes prevalent, 
chronic CV complications with life-threatening outcomes. CAN is characterized by 
damage to the autonomic nerve fibers regulating HR, cardiac output, myocardial 
contractility and blood vessel constriction/dilation, which causes a wide range of cardiac 
disorders (Balcıoğlu & Müderrisoğlu, 2015). Diabetic risk factors such as hyperglycemia, 
older age, obesity, and physical inactivity all contribute to CAN (Vinik & Ziegler, 2007). 
CAN is often overlooked due to clinical symptoms appearing late in the progression of 
the disease. Clinical manifestations include resting tachycardia, orthostatic hypotension, 
exercise intolerance, hypertension and silent myocardial infarctions (MI) (Vinik & 
Ziegler, 2007). Autonomic denervation is partly reversible and can be slowed down in the 
early stages of disease, therefore early detection and screening for autonomic dysfunction 
in patients with T2D is crucial. Reduced heart rate variability (HRV) may be a potential 
early indicator of autonomic dysfunction and can be seen at subclinical stages of disease 
(Matei et al., 2013; Thayer et al., 2010; Vinik & Ziegler, 2007)). 
1.5  Heart Rate Variability 
HRV is a non-invasive measure of cardiac autonomic regulation (Britton et al., 2008), 
which may be a promising tool for early diagnosis. Measurement of HRV involves the 
collection of consecutive R-R intervals (RRI) (Figure 1) from either an electrocardiogram 
(ECG) or HR monitor. Long-term recordings of 24-hour duration and short-term 
recordings of five minutes duration are commonly analysed (Figure 2). A high HRV 
reflects cardiac adaptability and implies good health, as seen in healthy populations, while 
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low HRV reflects autonomic dysfunction, as seen in clinical populations (Grieco et al., 
2014; Balcıoğlu & Müderrisoğlu, 2015). It is important that HRV only be compared 
within or between individuals if the same length of data was analyzed, due to variability 
being length-dependent (Task Force of the European Society of Cardiology, 1996). Non-
sinus beats such as ectopic beats, noise, and premature ventricular contractions should be 
removed prior to HRV analysis (Kamath et al., 2012). HRV analysis methods are divided 
into linear (time and frequency domains) and non-linear methods.   
 
 
 
 
 
Figure 1: ECG signal—Depicting the RRI used to assess HRV (Thompson, 2010). 
 
1.5.1 Time Domain Analysis 
Time domain parameters are easily calculated. The most common time domain parameter 
of HRV is the standard deviation of normal-to-normal RRI (SDNN). Other parameters 
include root mean square of successive RRI differences (RMSSD) and percentage of RRI 
with difference >50ms (pNN50) (Kamath et al., 2012). RMSSD and pNN50 represent 
rapid vagal responses in RRI, while SDNN has both SNS and PNS activity and represents 
overall autonomic activity (Matei et al., 2013). The main limitation of this method is the 
lack of discrimination between the effects of sympathetic and parasympathetic autonomic 
branches (Kamath et al., 2012).  
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Figure 2: Consecutive R-R intervals—Depicting consecutive RRI (Task Force of the European Society of 
Cardiology, 1996) 
1.5.2 Frequency Domain Analysis 
Power spectral density (PSD) is a more advanced analysis of HRV than the time domain 
analysis and has been used extensively in research. In the frequency domain, HRV is 
described as the sum of oscillatory components and defined by frequency and amplitude 
(power) (Chemla et al., 2005). Total power (TP) of the RRI is represented by the total 
area under the PSD curve. The power spectrum consists of four power frequency bands: 
ultra low frequency (ULF; 0-0.003Hz), very low frequency (VLF; 0.003-0.04Hz), low 
frequency (LF; 0.04-0.15Hz) and high frequency (HF; 0.15-0.4Hz) (Kamath et al., 2012). 
LF and HF are generally conveyed as short-term spectral components whereas ULF and 
VLF require long-term recordings to perform valid analysis. LF and HF can be expressed 
as a ratio LF/HF to emphasize the sympathovagal balance between PNS and SNS activity 
(Task Force of the European Society of Cardiology, 1996). HF represent vagal activity 
and LF includes both PNS and SNS effects. Increases in LF/HF are assumed to reflect a 
shift to sympathetic dominance, while decreases correspond to parasympathetic 
dominance (Billman, 2013). However, despite wide acceptance of the LF/HF ratio, it 
remains a controversial measure of sympathovagal balance in healthy and disease 
populations (Billman, 2013). Billman (2013) proposed that the LF/HF representing 
sympathovagal balance rested upon four assumptions: 1) SNS activity is exclusively 
responsible for the LF peak in the HR power spectrum; 2) PNS activity is exclusively 
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responsible for the HF peak in the HR power spectrum; 3) disease or physiological 
challenges provoke reciprocal changes in SNS and PNS activity; and 4) there is a simple 
linear interaction between the effects of SNS and PNS activity on HRV. Billman 
concludes that the LF/HF ratio cannot accurate quantify cardiac sympathovagal balance 
in healthy or disease populations (Billman, 2013). 
Frequency bands are thought to represent physiological processes and are used to estimate 
the contributions of PNS and SNS contributions in HR. The physiological background of 
ULF and VLF bands are not well known and attributing physiological explanation may be 
called into question (Task Force of the European Society of Cardiology, 1996). LF and 
HF bands are more commonly used in HRV analysis. LF bands are mediated by both the 
sympathetic and parasympathetic branches of the ANS, whereas HF bands are primarily 
mediated by parasympathetic branches (Tarvainen et al., 2013; Kamath et al., 2012). HF 
corresponds to HR variations related to respiratory sinus arrhythmia and fluctuations in 
PNS activity. Breathing volume and frequency influence HRV measures; as breathing 
volume decreases, so does HF power (Kamath et al., 2012). Roughly speaking, SNS 
activity increases HR and decreases HRV, whereas PNS activity decreases HR and 
increases HRV (Tarvainen et al., 2013). 
In a normal population, the ability of the CV system to maintain a high level of variability 
is a sign of health. Conditions such as chronic heart failure are characterized by high SNS 
drive to both the heart and peripheral blood vessels and would be expected to manifest as 
predominantly LF oscillations, which however, is not the case (Van De Borne et al., 
1997). In severe cardiac disease conditions, such as chronic heart failure, LF and thus 
LF/HF, are unable to measure SNS drive due to impaired BRS regulation and tonic SNS 
activation without LF oscillatory patterns (Van De Borne et al., 1997). 
Methods for calculating PSD provide information on the power distribution across 
frequencies and are classified as either nonparametric or parametric (Task Force of the 
European Society of Cardiology, 1996). The fast Fourier transform (FFT) is the most 
commonly used nonparametric method. FFT is a simple algorithm used to convert the 
time domain data into frequency domain data, and is not filtered prior to processing 
(Kamath et al., 2012). FFT allows the signal to be easily interpreted using a graphical 
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representation of the data (Figure 3). The power spectrum is divided into VLF, LF and 
HF bands (Task Force of the European Society of Cardiology, 1996). The resolution of 
the frequency scale depends on the number of data samples and the sampling interval. A 
low sampling rate may produce a jitter and may not be a good representation of the 
original signal. Alternatively if the sampling rate is too high, the signal is accompanied by 
spectral noise and inaccuracies. Applying a linear regression analysis to the HRV signal 
decreases the error (Kamath et al., 2012). Between each adjacent signal there is overlap 
causing leakage (loss of data) between frequencies in the power spectral estimate. 
Leakage from one frequency into the other can be corrected for using data windowing 
(i.e. Hanning) to smooth the spectral signal (Kamath et al., 2012). 
 
 
 
 
 
 
Figure 3: FFT spectral analysis—Depicting the VLF, LF and HF peaks of the signal (Task Force of the 
European Society of Cardiology, 1996) 
 
Autoregression (AR) is a parametric model that is used to analyze RRI and determine the 
central frequency (frequency peaks) and powers of the oscillatory components. Each time 
series (RRI) depends linearly on the previous time series values (Kamath et al., 2012). 
The advantages of parametric methods are simplicity of the algorithm, high processing 
speed (Task Force of the European Society of Cardiology, 1996) and smoother spectral 
components that can be distinguished independently of the frequency bands (Pichon et al., 
2006). Similar to FFT, the AR model requires a set of parameters (model order) to 
establish the correct model order of the frequency spectrum. The Akaike information 
criteria is employed as a measure of model quality and Burg’s algorithm is used to select 
the specific model order (Kamath et al., 2012). Excessively high model orders capture 
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noise and produces a spectrum with false or split peaks, while too low a model order 
smooths spectral peaks, causes peak shifting or removes peaks altogether (Kamath et al., 
2012). The AR model is also divided into VLF, LF and HF bands (Figure 4).  
                                    
Figure 4: AR spectral analysis—Depicting the VLF, LF and HF bands of the spectrum (Task Force of the 
European Society of Cardiology, 1996) 
1.5.3 Non-Linear Analysis 
Non-linear analysis methods of analyzing HRV also elicit valuable information for 
physiological interpretation and the risk of sudden death (Task Force of the European 
Society of Cardiology, 1996). Commonly used non-linear HRV methods are: Poincaré 
plot, sample entropy, detrended fluctuation analysis (DFA) and Coarse Graining Spectral 
Analysis (CGSA). The Poincaré plot is a scatterplot between successive RRI (Figure 5). 
They are used to extract indexed such as short-term variability (width; SD1) and long-
term variability (length; SD2) which are non-linearly connected to time-domain 
parameters (Goit et al., 2014; Tarvainen et al., 2014; Kamath et al., 2012). Sample 
entropy is a commonly used measure of signal complexity of short time series and is 
computed using an embedding dimension of length (m=2) and tolerance of 0.2 times the 
standard deviation of the time series (Tarvainen et al., 2014). Sample entropy is not 
sensitive to changes in single data values, however it is sensitive to factors that affect 
tolerance parameters (i.e. ectopic beats) (Kamath et al., 2012). DFA is a measure of self-
affinity of a signal, separated into short-term (α1) and long-term (α2) fluctuations within 
the RRI time series (Tarvainen et al., 2014). And finally, CGSA samples every other data 
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point of the time series to eliminate noise, which allows for more accurate quantitative 
analysis by acquiring clearer peaks in the LF and HF bands (Yamamoto & Hughson, 
1991).  
                    
Figure 5: Poincare plot—Depicting SD1 and SD2 (Karmakar, 2009) 
 
1.5.4 Heart Rate Variability during Postural Changes 
Changes in body position or posture can alter the activity of SNS or vagal influence on 
HR in a T2D population (Mahananto et al., 2015). Positions such as sitting and standing 
undergo physical challenges imposed by gravity, which cause a temporary drop in BP and 
increase in HR (Michel-Chávez et al., 2015). As the posture becomes more physically 
demanding, initial decreases in HF and increases in LF are observed (Malliani et al., 
1991). After approximately one minute of sitting or standing, HRV parameters are 
regulated by the body’s negative feedback mechanism and stabilized back to a 
homeostatic “set point” (Finucane et al., 2014; Zhang, 2007). In T2D, this “set point” is 
influenced by greater SNS activation, and results in higher HR, LF and reduced HF.  
1.5.5 Heart Rate Variability as a Diagnostic Tool 
HRV is used extensively in research and is considered a valuable clinical tool due to its 
simplicity and non-invasiveness. Clinical applications of HRV include assessment of risk 
of death after an MI, monitoring disease progression of congestive heart failure and early 
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diagnosis of autonomic dysfunction (Malik, 1998). The usefulness of HRV has expanded 
from cardiac applications to utilization during exercise and diverse pathological 
conditions, such as chronic renal failure, autonomic neuropathy, fibromyalgia and 
hypertension (Kamath et al., 2012). Several studies have investigated the usefulness of 
short-term HRV analysis by examining autonomic imbalances (exhibited as reduced 
HRV) that occur in the aforementioned pathological conditions. Power spectral analysis 
of HRV has also been considered a useful tool in assessing autonomic function in patients 
with T2D (Canani et al., 2013).  
In a longitudinal study on aging, researchers investigated the association between HRV 
and cognitive performance (as measured by MOCA). A multivariate linear regression was 
used to model the association between HRV and cognition. Results indicated that lower 
quantiles of SDNN, LF and LF/HF ratio were significantly associated with poorer MOCA 
scores (Frewen et al., 2013). A possible explanation for the association between reduced 
HRV and cognitive decline could be the cholinergic anti-inflammatory pathway. Efferent 
vagal nerve activity inhibits pro-inflammatory cytokine release, which protects against 
systemic inflammation. Reductions in LF, HF and SDNN, along with an increase in HR 
are associated with higher levels of C-reactive proteins and interleukin-6, which are both 
associated with cognitive decline. Therefore, inflammation may mediate the relationship 
between reduced HRV and cognitive performance (Frewen et al., 2013). Thus, HRV may 
have potential predictive application in cognitive decline. 
1.6 Type 2 Diabetes Management  
1.6.1    Pharmaceuticals 
Glycemic control in T2D is managed via pharmaceutical treatments and/or through diet 
and exercise. Lifestyle management, through diet and exercise are initially prescribed, 
however if there is poor adherence and glycemic targets are not met in the first 2 to 3 
months, pharmaceuticals are administered (Canadian Diabetes Association, 2008). Most 
T2D patients will require insulin therapy to maintain long-term glycemic control, either 
as a monotherapy or combined with oral antidiabetic therapy (Krentz & Bailey, 2005). 
There are many oral antidiabetic medications available. The main classes include agents 
that stimulate insulin secretion (sulphonylureas and rapid-acting secretagogues), reduce 
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hepatic glucose production (biguanides), delay digestion and absorption of intestinal 
carbohydrate (α-glucosidase inhibitors) or improve insulin action (thiazolidinediones) 
(Krentz & Bailey, 2005). Metformin, a biguanide agent, is widely regarded as the drug of 
choice for patients with T2D as it improves insulin sensitivity and decreases insulin levels 
(Kravitz et al., 2013). Initial monotherapy with metformin does not promote weight gain, 
unlike other antidiabetic medications, and has beneficial effects on CVD risks such as 
reduced MI and diabetes-related deaths (Krentz & Bailey, 2005). 
In a study by Knowler et al (2002) pre-diabetic individuals were randomly assigned to 
either placebo, metformin (850mg twice daily), or a lifestyle modification program (150 
minutes of moderate-intensity exercise per week; low-calorie, low-fat diet). After three 
years, researchers found the incidence of T2D was 11.0, 7.8 and 4.8 cases per 100 people 
in the placebo, metformin and lifestyle intervention groups respectively. The lifestyle 
intervention significantly reduced the risk of T2D by 58% while metformin reduced the 
risk of T2D by 31% (Knowler et al., 2002). Lifestyle interventions are better short- and 
long-term regulators of T2D and should therefore be an essential constituent in both the 
prevention and treatment of T2D.  
1.6.2 Aerobic Exercise in Type 2 Diabetes 
Extensive literature exists on the effects of aerobic exercise in healthy and clinical 
populations. Aerobic exercise, also known as endurance exercise, utilizes the 
cardiorespiratory systems to perform exercise. In aerobic exercise, the circulatory and 
respiratory systems work together to supply oxygenated blood to the working skeletal 
muscles during prolonged exercise (Hayes et al., 2014). According to the American 
College of Sports Medicine (ACSM) and American Diabetes Association, people with 
T2D should accumulate at least 150 minutes of moderate to vigorous aerobic exercise a 
week, spread out over at least 3 days of the week, and with no more than 2 consecutive 
days of rest in between (Colberg et al., 2010). CV protective results are not immediately 
observed with acute aerobic exercise, and due to the exercise intolerance commonly seen 
in individuals with T2D (caused by excessive weight and low respiratory fitness), 
adherence to exercise is low, outweighing the associated positive benefits (Grieco et al., 
2014). Special exercise considerations for T2D individuals should be implemented to 
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increase compliance. Exercise can be modified to better accommodate overweight 
individuals by dividing exercise time into smaller intervals and reducing intensity. Blood 
glucose levels should also be monitored before and after exercise to prevent 
hypoglycemia during exercise (American College of Sports Medicine, 2013). Strong 
dose-response relationships are documented between regular exercise and reduced risk of 
conditions such as CVD, T2D, hypertension, and cognitive decline (American College of 
Sports Medicine, 2013).  
Aerobic Exercise and Cognition 
Overall, evidence suggests that exercise has cognitive benefits that may offset declines 
associated with aging and disease (Hayes et al., 2014). Cognitive gains achieved with 
aerobic exercise training are most prominent in executive functions, processing speed and 
episodic memory, which are processes required for daily living (Hayes et al., 2014).  
Reduced physical fitness is associated with brain alterations, reduced cerebral blood flow, 
increased white matter lesions, a thinner cortex and smaller total and regional (i.e. 
hippocampus, cingulate gyrus)  grey matter volume in CVD populations (Hayes et al., 
2014). Research suggests exercise may attenuate adverse brain changes in CVD through 
improvements in physical fitness and subsequent increased cerebral perfusion (Hayes et 
al., 2014).  
Baker et al (2010) extended these findings by observing improvements in executive 
function, cardiorespiratory fitness and insulin sensitivity following 6-months of aerobic 
exercise intervention (45-60 minute sessions, 75-85% HR reserve, 4 days per week) when 
compared to the control group (<50% HR reserve; balance and stretching exercises) in 
older glucose intolerant adults. In addition, circulating levels of the Alzheimer biomarker 
Aβ42 tended to decrease for subjects in the aerobic group relative to the control (Baker et 
al., 2010).  
In contrast, a study by Fiocco et al (2013) examined the effects of a 24-week intervention 
program (60 minutes combined aerobic and resistance exercise; 30 minute lecture) on 
cognitive performance, and CV and metabolic factors. Results showed an increase in CV 
fitness and peak HR, and a decrease in body mass index and depressive symptoms. 
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Surprisingly however, analysis showed that cognitive performance on immediate recall, 
short-delay recall and category fluency (as measured by the California Verbal Learning 
Test, Digit Symbol Substitution Task and fluency test respectively) declined following 
the intervention (Fiocco et al., 2013). It was concluded that due to small sample size and 
lack of control group, the findings of this study should be interpreted with caution. 
Furthermore, it was suggested that the addition of hypertension exacerbated the 
deleterious effects of T2D on cognitive function.  
A systematic review by Angevaren et al (2008) concluded that aerobic exercise is 
beneficial for cognitive function in healthy older adults. Effects were observed for motor 
function, cognitive speed, auditory and visual attention, however, the majority of 
comparisons yielded no significant results and larger studies were required. Alternatively, 
the National Institutes of Health State of Science Conference Statement on Preventing 
Alzheimer’s Disease and Cognitive Decline concluded that data were insufficient to state 
that aerobic exercise improved or maintained cognitive function (Daviglus et al., 2010). A 
meta-analysis of randomized control trials (RCT) found a small, higher quality study that 
showed modest benefit in reducing cognitive decline following exercise in people with 
confirmed memory problems; however, the data is considered preliminary and further 
investigation is required (Daviglus et al., 2010). 
Aerobic Exercise and Heart Rate Variability 
The effects of exercise on HRV have been examined thoroughly among patients with 
T2D, however, findings have been inconclusive. In healthy individuals, aerobic exercise 
training typically increases vagally mediated HRV (Tulppo et al., 2003), the increased 
stroke volume of the heart being the most potent mechanism in this response (Cornelissen 
& Fagard, 2005). Zoppini et al (2007) examined long-term CV autonomic adaptation to 
moderate aerobic exercise in individuals with T2D. Following 6-months of aerobic 
training (twice weekly, 1 hour sessions, 50-70% HR reserve), there were no exercise-
related changes in power spectral analyses or LF/HF ratio in the prone position. In a 
standing position, however, HF was significantly increased and LF and LF/HF ratio were 
significant decreased. Researchers infer that moderate aerobic exercise significantly 
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improves CV autonomic function in T2D individuals, however the study did not comply 
with ACSM exercise recommendations in T2D.  
These findings were enforced by a study that did meet exercise guidelines by Goit et al 
(2014) on the effects of 6-months of aerobic exercise intervention (3 days per week, 
moderate-intensity exercise) in T2D individuals. The results showed that the time domain 
parameters reflecting PNS activity (RMSSD and pNN50) were significantly increased, 
whereas SDNN, representing both SNS and PNS activity, was unaffected after exercise. 
Findings were also significant in the frequency domain; an increase in HF and decrease in 
both LF and LF/HF ratio were observed. The non-linear findings showed a significant 
increase in Poincaré plot SD1, whereas SD2 was unaffected following exercise (Goit et 
al., 2014).  
Contrarily, Loimaala et al (2003) concluded that 12-months of exercise training (aerobic 
exercise 2 times per week at 65-75% maximal oxygen intake (VO2max); strength training 
2 times per week at 70-80% maximal voluntary contraction, 3 sets of 10-12 repetitions) is 
not long enough to improve HRV in T2D patients. However, a decrease in HR suggested 
vagal tone was likely increased following training. There was also a nonsignificant trend 
towards improved HRV parameters in the exercise group, suggesting a longer training 
period could improve HRV in T2D. 
In clinical populations, HRV parameters reflecting PNS activity have been shown to 
increase whereas parameters reflecting SNS activity have been observed to decrease 
following aerobic exercise training. These findings suggest that individuals with initial 
low HRV are responsive to changes in HRV following aerobic exercise (Brown & 
Brown, 2006). However, improved autonomic function is not consistently observed with 
exercise training, for instance, in CAD patients regardless of comorbid T2D (Karjalainen 
et al., 2015). 
1.6.3 Resistance Exercise in Type 2 Diabetes 
As opposed to the extensive literature on aerobic exercise, fewer studies have examined 
the effects of resistance training. Resistance training, also known as strength training or 
weight training, is any exercise that causes the muscles to contract against an external 
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resistance with the intent to increase muscle strength and mass (American College of 
Sports Medicine, 2013). Resistance exercise is recommended at least 2-3 days/week for 
people with T2D as part of a well-rounded exercise program by ACSM (Colberg et al., 
2010). It maintains or increases skeletal muscular strength, prevents osteoporosis and 
lowers the risk of all-cause mortality and CVD events (American College of Sports 
Medicine, 2013). 
Resistance Exercise and Cognition 
Resistance exercise plays a role in cognitive function. In a study by Cassilhas et al (2007), 
improvements were found in global cognitive function following both moderate- and 
high-intensity resistance training when compared to control, with no difference between 
the two intensities. Since the beneficial effects did not depend on the intensity of exercise, 
moderate-intensity resistance exercise may be more appropriate for an elderly population. 
Following resistance exercise, participants experienced better brain blood flow, and 
transportation of nutrients and oxygen, which is a likely mechanism for the improved 
cognitive performance (Cassilhas et al., 2007). 
In a comparative study by Ozkaya et al (2005), researchers investigated the effects of 9-
weeks of either moderate strength or endurance exercise training on cognition, evaluated 
by event-related potentials in older individuals. Participants were divided into either 
aerobic training (50 minutes/session, 3 times per week, at 70% heart rate reserve), 
strength training (7 exercises, 12 repetitions, 60-80% of 1 repetition maximum, 3 times 
per week) or control. Ozkaya et al (2005) found no differences in functional fitness 
between the strength and endurance training groups, however strength training may have 
facilitated effects on early information processing and cognition. They concluded that 
changes in cerebral blood flow, neurotransmitter functioning or increased cell complexity 
might occur in different brain regions and contribute to central nervous system integrity, 
however, the mechanisms behind the event-related potentials remain unknown and their 
preliminary findings await replication in a larger sample size (Ozkaya et al., 2005). 
Positive advancements have been made on the effects of resistance exercise on cognition, 
however research is limited and results have been modest.  
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Resistance Exercise and Heart Rate Variability 
There is currently no research on the sole effects of resistance training on HRV in T2D 
population, however, effects have been investigated in other diseases affecting cardiac 
autonomic function. In a study examining the effects of a 3-month moderate-intensity 
resistance exercise training program (circuit training, 3 times per week) in chronic heart 
failure participants, significant increases in HRV (increase in HF power and decrease in 
LF power and LF/HF ratio) were observed (Selig et al., 2004). More recently, Figueroa et 
al (2008) conducted a study on 16-weeks of moderate-intensity resistance training (30 
minutes circuit training, 2 times per week, 8-12 repetitions, 50-80% of 1 repetition 
maximum) in women with fibromyalgia who had pre-training reductions in HRV. 
Findings showed increased HRV (increase in TP and HF power) following the training 
program (Figueroa et al., 2008). The mechanisms involved in these responses are 
believed to be a result of increased peripheral SNS activity stimulating the BRS which in 
turn promotes a decrease in SNS and an increase in cardiac PNS activity (Lima et al., 
2011). Likewise, the improvements in cardiovagal control following resistance exercise in 
those with autonomic dysfunction may be due to a greater physical deconditioning and 
adiposity (Kingsley and Figueroa, 2016). 
1.6.4 Cognitive Exercise  
Interventions that rely on complex mental activities present a new approach to combating 
age-related decline and dementia (Gates & Valenzuela, 2010). Cognitive exercise or 
training is defined by Gates & Valenzuela (2010) as a standardized set of mental 
exercises that are repeated and focus on specific cognitive functions that progressively 
become more difficult. Benefits from cognitive training in older cognitively intact adults 
remains controversial, however longitudinal RCTs implementing cognitive training in 
older adults without cognitive impairment have been shown to slow the rate of age-
related cognitive decline (Gates & Valenzuela, 2010).  
In a large scale study by Ball et al (2002), older adults without cognitive impairment were 
randomized into either training for memory (verbal episodic memory), reasoning 
(problem solving serial patterns), speed of processing (visual search and identification) or 
a control group. Findings showed that cognitive interventions improved normal elderly 
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individuals’ performance on the cognitive tasks for which they were trained. Although the 
impact of training had decreased after 2 years, participants in the cognitive intervention 
groups had significantly better cognitive skills than individuals in the control group.  
Likewise, Klusmann et al (2010) found that 6-months of cognitive training (cognitive 
computer course) had similar effects to that of the exercise intervention (aerobic, 
resistance and flexibility training) on episodic memory in older women with MCI. They 
conclude that different activity types (mental activity or exercise) are equally suitable for 
maintaining cognitive performance in older women with MCI. Multimodal cognitive 
training has also been suggested to provide greater benefit than unimodal (Gates & 
Valenzuela, 2010) which demonstrates the importance of researching interventions that 
combine exercise with cognitive training.  
Square-Stepping Exercise 
The square-stepping exercise (SSE) program was developed by Shigematsu & Okura in 
Japan as a fall prevention strategy to aid participant balance and reduce the incidence of 
falls in the elderly (Shigematsu & Okura, 2006). SSE was found to be as effective, if not 
more so, than strength and balance training when preventing falls in older adults 
(Shigematsu et al., 2008) and is now starting to show the possibility of improving 
cognitive status among older adults. SSE is a form of mind-motor exercise, which 
combines both cognitive and mild exercise tasks. SSE is low cost, easily administered and 
social group-based exercise intervention that can be described as a visuo-spatial working 
memory task with a stepping response. One recent study by Teixeira et al (2013) revealed 
positive influences on global cognitive function (MMSE score), concentrated attention 
(Toulouse-Pierón Attention Test) and mental flexibility (Modified Card Sorting Test) 
following 16-weeks of SSE (40 minute sessions, 3 days per week) among older adults.  
These findings were supported by a study by Gill et al (2016), who found that following a 
26-week intervention (exercise and dual task), there were improvements in global 
cognitive function when compared to control (exercise only). Both exercise groups 
performed either a minimum of 50 minutes (classes 2 times per week) to a maximum of 
75 minutes (classes 3 times per week) of aerobic exercise. In combination with the 
aerobic exercise, both groups took part in beginner-level SSE (45 minutes per week, 2 to 
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3 days per week). In addition to the beginner-level SSE, the dual-task group were 
required to respond to cognitively challenging questions while participating in SSE. 
These results indicate that there are further improvements in cognitive function when 
combining a dual task with exercise. Improvements however were not seen at 12-weeks 
nor 26-weeks following the completion of the intervention. SSE as a form of cognitive 
training is a recent development, and few studies have investigated its effect on cognition. 
Currently there have been no reports in the literature observing the effects of SSE on 
functional fitness, such as HR and BP (Teixeira et al., 2013) nor have there been any 
studies on the effects of SSE on HRV. More high-quality studies are needed to assess the 
effects of SSE on HRV in older adults experiencing cognitive decline. 
1.7 Summary 
The current literature review highlights areas of research that are lacking and require 
further investigation. As previously stated, the effect of exercise on alleviating cognitive 
decline in T2D remains limited and incongruous. The presence of T2D has been 
previously linked to autonomic dysfunction, however to date, there is a lack of research 
and mixed findings to show whether or not low HRV, as seen in T2D, is associated with 
cognitive impairments and dementia. An improvement in HRV has been observed in 
traditional aerobic and resistance exercises in clinical populations, however little research 
has been done on novel cognitive exercises such as the SSE. The SSE is a relatively new 
group-based exercise program that has only recently been implemented in cognitive 
research. The SSE is beneficial through its multifaceted impact on cognition, not only 
combining visuo-spatial memory tasks with mild exercise, but ascertaining social benefits 
through a group environment. It is believed that such a novel cognitive exercise, suitable 
for older and disease populations, can be seen to develop new steps in addressing the 
prominent issues related to mitigating autonomic dysfunction and cognitive decline.  
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Chapter 2 
The effect of a square-stepping exercise intervention on heart rate variability in 
older individuals with type 2 diabetes and subjective cognitive complaints 
2.1 Introduction 
The findings from the aforementioned literature demonstrate the necessity for an 
intervention-based study in older diabetic adults. Therefore, the primary objective of this 
RCT was to investigate HRV parameters (time and frequency domains) in community-
dwelling older adults with T2D and subjective cognitive complaints following a 24-week 
SSE intervention. A secondary objective was explored to determine if there was a 
relationship between HRV parameters (HR and RMSSD) and global cognitive function 
following 24-weeks of SSE training. Lastly, a tertiary objective was used to examine the 
effects of this novel intervention on other CVD risk factors associated with T2D, such as 
resting BP. It was hypothesized that HRV parameters representative of predominant SNS 
activity would be high and HRV parameters representative of PNS activity would be low 
in all participants at baseline. Following 24-weeks of SSE training, it was further 
hypothesized that the intervention group would shift towards predominant vagal 
modulation (increased RMSSD and HF and decreased HR, SDNN, LF and LF/HF), with 
no change in the control group (Task Force of the European Society of Cardiology, 1996). 
These shifts towards vagal modulation were speculated to only be observed in the sitting 
and standing postures due to the physical challenges imposed by gravity (Michel-Chávez 
et al., 2015). It was hypothesized that RMSSD (a measure chosen to represent 
predominant PNS activity) would exhibit a positive correlation with global cognitive 
function following 24-weeks of SSE training, with no change in the WL group. 
Contrarily, HR (a measure chosen to represent predominant SNS activity) would exhibit a 
negative correlation with global cognitive function following 24-weeks in the SSE group 
with no change in the WL group. Finally, resting SBP and DBP were predicted to 
decrease following 24-weeks in the SSE group, with no change in the WL group 
(Cornelissen & Fagard, 2005). 
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2.2 Methods 
The current study was a pilot-study of a larger 2-site RCT conducted out of London and 
Woodstock, Ontario, Canada. The larger study was designed to investigate the effects of a 
square-stepping exercise on global cognitive function and was cleared by the Health 
Sciences Research Ethics Board at Western University (REB# 105883; Appendix A; 
Appendix B; Appendix C). All participants provided written informed consent prior to 
enrolling in the study. Outcome measures were recorded at baseline, following 12-weeks 
(interim) and 24-weeks (intervention end point) of the exercise intervention. 
Participants 
Twenty-five older adults over the age of 50 years (range: 54 to 82 years; 8 women) with 
stable T2D and self-reported cognitive complaints were recruited from both sites (London 
and Woodstock). Participants were recruited using a variety of methods including posters, 
newspapers, electronic medical records, local stress test database, previous study lists 
(i.e., approved by ethics to go back to individuals from former studies) and a community-
base, hospital supported Primary Care Diabetes Program. Once informed consent was 
completed and the participants were deemed eligible through a screening process, 
participants were randomized. A randomization stratification of 1:1 was used and 
balanced at every 4 participants. The person who generated the sequence was independent 
of those doing the allocation. Allocation involved concealed envelopes, to keep the 
randomization unknown to the assessors until after the screening process. 
Study Design 
This study was designed as a 24-week RCT, whereby participants were randomized into 
either a SSE intervention or a WL control group. Participants randomized into the 
intervention group took part in 24-weeks of SSE. The WL group did not receive 
supervised exercise sessions during the initial 24-week period. Participants were 
instructed to continue their daily routines, and keep their eating and exercise habits the 
same. Following the initial 24-week period, the WL group began the 24-week SSE 
program.  
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The study was broken down into three waves to enroll more participants into the RCT. 
Waves 1 and 2, containing twelve and six participants respectively, were held in London. 
Wave 3, containing seven participants, was located in Woodstock. All participants from 
both London and Woodstock were included in the same analyses.  
Location 
All assessments for Waves 1 and 2 were held in London and all assessments for Wave 3 
were held in Woodstock. Screening and baseline assessments were conducted at St. 
Joseph’s Primary Care Diabetes Clinic (London), the University of Western Ontario 
(London) and the Salvation Army Community Church (Woodstock). Final assessments 
were conducted at the University of Western Ontario and the Salvation Army Community 
Church. The exercise classes were held at the Stoney Creek Young Men’s Christian 
Association (YMCA) in London and the Woodstock YMCA. 
Screening 
Screening was implemented to ensure subjects met the correct inclusion criteria. 
Screening comprised of reading the study’s letter of information (LOI) and consenting 
documentation. Tests and questionnaires including the MMSE (as an assessment of 
cognitive function) and the CES-D (to determine the presence of severe depression) were 
administered. Participants were also required to agree to attend a minimum of 75% of 
sessions. 
Inclusion/Exclusion Criteria 
Participants were deemed eligible to participate in the study if they were 50 years of age 
or older, had stable T2D, and self-reported a cognitive complaint. Stable diabetes was 
defined as having an HbA1c of <9.0mmol/L (at the advice of Dr. Sonja Reichert and Dr. 
Stewart Harris) for the past 6 months (last 2 readings). These values were verified using 
electronic medical records. A self-reported cognitive complaint was defined as believing 
that one’s thinking and/or memory had gotten worse recently (recently was subjective). 
Participants were excluded if they displayed any of the following criteria: clinical 
depression (CES-D score ≥16 needed confirmation from a physician), diagnosis of 
dementia, diagnosis of other neurological disorders (i.e. Parkinson’s disease), severe 
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history of CV event (within the past 12 months), severe orthopedic limitations that could 
impair ability to exercise, uncontrolled diabetes (HbA1c >9.0mmol/L), unstable angina, 
untreated retinopathy, foot ulcers with or without severe peripheral neuropathy, severe 
sensory impairment and the inability to commit to 75% of sessions. Those eligible for the 
study, continued on to baseline assessments. 
Assessments 
In addition to the following assessments, participants were taken through a battery of 
measures that pertained to the larger study outcomes, and will not be discussed in the 
current paper. A flowchart of assessments pertaining to the current study can be found in 
Figure 6. Participants were termed “non-compliant” if they did not attend assessments at 
24-weeks. 
Baseline Assessment 
Demographic information including age, sex, ethnicity, marital status, general health 
(smoking status, drinks consumed in a typical week), duration of T2D, duration of 
subjective cognitive complaint, years of education, number of medications and medical 
history/conditions were obtained. The Montreal Cognitive Assessment (MOCA) and the 
clock drawing test were administered as part of the cognitive assessments. 
Anthropometric measures including weight, height, body mass index (BMI), and waist 
circumference were recorded. Participants then underwent the HRV protocol and resting 
HR and BP measures. Finally, participants were introduced to twelve Cambridge Brain 
Sciences (CBS) computer games. Further explanations for anthropometric measures, 
HRV and CBS games are located below in the Instruments and Measures section. The 
baseline assessments lasted approximately 1.5 hours. 
Interim Assessment 
CBS was the only assessment conducted at 12-weeks for the current study.  
Final Assessment 
A list of each participant’s medication was updated at final assessments. The CBS games, 
HRV and resting HR and BP were collected.  
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Figure 6: Assessment flowchart—Assessments collected at baseline, interim and completion of study. 
Instruments and Measures 
Anthropometrics 
Anthropometric measurements included the participant’s height (m), weight (kg), waist 
circumference (cm) and body mass index (kg/m2). Height was measured using a 
stadiometer and weight was measured using a standard scale. Measurements were taken 
with clothing (large sweaters and coats were removed) and without shoes. According to 
the Canadian Diabetes Association Clinical Practice Guidelines, waist circumference was 
measured by placing a measuring tape just above the lateral border of the iliac crest, and 
instructing the participant to take two normal breaths. The measuring tape was tightened 
until snug upon the second exhale (Managing Weight & Diabetes, 2013). If the difference 
between the first two measures was greater than 0.5cm, a third measure was taken, and 
the three recordings were averaged. BMI was calculated using height and weight 
measurements. 
Heart Rate Variability and Blood Pressure 
Participants were instructed to stand and lift their shirt while their chest was scrubbed 
with an alcohol swab along the ribs at the level of the xiphoid process. The Suunto 
Memory Belt, containing 2 electrodes on the posterior surface, was wet with water and 
placed snugly around the chest directly on the skin (Suunto User's Guide, 2014). The 
participant was instructed to sit on the examining table while an automated 
sphygmomanometer (BpTRUTM) was placed over the brachial artery on either the left or 
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right arm before lying down to begin the supine-sit-stand protocol. The protocol consisted 
of 10 minutes of supine, 10 minutes of sitting and 6 minutes of standing (Figure 7). 
Protocol times were established to provide accurate HRV recordings in the final 5 
minutes of each position while excluding transitional influences. Standing time was set to 
6 minutes because the orthostatic HR response is stabilized after approximately one 
minute of standing (Finucane et al., 2014) and for some participants it would have been 
difficult to remain standing for 10 minutes. 
 
 
Figure 7: Timeline of HRV protocol—10 minutes of supine, 10 minutes of sitting, 6 minutes of standing. 
 
Participants were instructed to stay as still as possible throughout the protocol and to 
breathe normally. Three resting BP and HR measures were taken halfway through the 
sitting position (at 15 minutes); readings were taken 2 minutes apart (Quinn et al., 2010). 
Recorded resting BP was measured as the average of the final two SBP readings over the 
average of the final two DBP readings. Resting HR was recorded as the average of the 
final two readings. 
Following the supine-sit-stand protocol, the following five questions were asked and 
answers were recorded on a datasheet:  
i. Have you consumed a large meal within the past 4 hours?  
ii. Have you had caffeine within the past 12 hours?  
iii. Have you smoked within the past 12 hours?  
iv. Have you performed vigorous exercise within the past 24 hours?  
v. Have you consumed alcohol within the past 24 hours?  
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The Suunto Memory Belt was then removed and the data was transferred to a personal 
computer (PC) using the Suunto Memory Belt docking station. The data was then 
retrieved from movescount.com as an Excel file and imported to the HEARTS software 
(Heart Signal Co., Oulu, Finland) for further HRV analysis.  
All RRI time series were visually scanned for ectopic beats and artefacts before being 
subjected to HRV analysis. During editing, segments consisting of 10 or more 
consecutive beats ectopic or non-sinus beats were deleted, while segments less than 10 
consecutive beats were interpolated (replaced with the average). Following editing, if the 
number of qualified beats (beats that were not subjected to editing) was less than 90%, the 
participant was excluded from analysis. HRV recordings were separated into 5 minute 
segments, including the last 5 minutes from each position. Spectral analysis was 
performed on each segment.  
Six HRV parameters were obtained for all three postural positions and used in analyses: 
heart rate (beats/min), standard deviation of normal-to-normal R-R intervals (ms), root 
mean square of successive R-R interval differences (ms), low frequency (ms2), high 
frequency (ms2) and the low frequency/high frequency ratio. For the correlation between 
HRV parameters and GCF, only HR and RMSSD were used in analyses. 
Cambridge Brain Sciences 
Global cognitive function, as well as domain-specific cognitive function was calculated 
using the CBS games. The CBS games were developed by Dr. Adam Hampshire and Dr. 
Adrian Owen and designed to effectively evaluate cognitive function in large-scale, 
population-based studies (Hampshire et al., 2012). The CBS consists of 12 games that test 
memory (Monkey Ladder, Spatial Span Blocks, Digit Span, Paired Associates Task), 
concentration (Rotation Task, Feature Match Task, Polygon Task), reasoning 
(Grammatical Reasoning Task, Double Trouble, Odd One Out) and planning (Hampshire 
Tree Task, Token Search) (Hampshire et al., 2012).  
Participants went through CBS assessments which took approximately one hour to 
complete. At baseline, participants went through familiarization with supervision from 
one of the research assistants. The purpose of familiarization was to get participants 
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acquainted with the games but also to prevent any learning effects that might occur due to 
the equipment. The games were randomly generated and constantly changed, so test-
related practice effects were eliminated (Hampshire et al., 2012). The CBS familiarization 
was done using a mouse on a Toshiba PC laptop with the volume turned up so that 
participants could hear the game cues. Subsequent CBS familiarization was unsupervised 
and completed at the home of the participant. In the event of a participant experiencing 
technical difficulties or not owning a computer with access to the internet, arrangements 
were made to complete the games on the study laptop. 
For CBS assessments, an email was sent to each participant with a link to the CBStrials 
website. Participants logged in using their email address and clicked “Play now”. 
Participants played all twelve games two times. The first round was for familiarization of 
the games and the second round was scored. Instructions appeared before each game 
commenced and participants were instructed to complete all 12 tasks in one sitting. The 
CBS tasks were expected to be completed within three days of the assessment, if not, a 
follow-up email was sent as a reminder. 
Composite scores for each cognitive domain was derived as follows: i) converting scores 
from each game into standardized z-scores (subtracting baseline group mean from the raw 
score and dividing by the baseline group standard deviation); ii) within each domain 
(memory, concentration, reasoning and planning), averaging game standardized scores to 
create domain-specific standardized scores; iii) the four domain-specific standardized 
scores were then averaged to create a global cognitive function (GCF) score (Monsell et 
al., 2012). 
Stepping Exercise Intervention 
The SSE interventions took place between June 2015 and May 2016. Wave 1 was from 
June to December 2015; Wave 2 was from October 2015 to April 2016; and Wave 3 was 
from December 2015 to May 2016. The intervention group attended 60 minute square-
stepping exercise sessions, twice a week on Tuesdays and Thursdays, for 24-weeks. Each 
session was broken up into 5-10 minutes of gentle warm-up suitable for diabetic patients, 
45 minutes of SSE, and 5 minutes of cool-down. SSE is a form of mind-motor exercise 
performed on a gridded floor mat (250cm by 100cm; partitioned in to 10 rows of 4 equal-
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sized squares), which combines cognitive tasks and mild exercise (Figure 8). A step 
pattern is demonstrated to the participants, who are then required to memorize and 
reproduce the pattern. Step patterns progressively become more difficult.  
Each pattern was required to be completed 4 times error-free by each participant, or to be 
completed 4 times error-free by 80% of the group, before moving on to the next pattern. 
If the participants were unable to recreate the pattern after the first demonstration, the 
pattern was repeated. If after a second demonstration the pattern was still not understood, 
pauses would be added between each step sequence. If the pattern was not understood 
following the pause, the steps were counted out loud for the participants. The sequences 
could consist of forward, backward, lateral and diagonal steps, which became more 
complicated as the exercise progressed (Figure 9). SSE participants were not allowed to 
view the clipboard that had the stepping patterns on it, nor were they allowed to review 
the patterns while they were not on the mat. While performing a pattern, support from 
other participants was encouraged. The idea was to keep the participants motivated and 
aid in adherence to the program. The program sequences were organized into Beginner, 
Intermediate and Advanced, each containing multiple sublevels (Appendix D). If all SSE 
patterns were performed before study completion at 24-weeks, existing patterns were 
recycled and randomized in Microsoft Excel to generate a pattern new order. All 
Advanced sublevels were included in the randomization i.e. Advanced 1-17, Advanced 2-
3, Advanced 3-21. 
 
 
 
 
 
 
 
Figure 8: Square-stepping exercise—Gridded floor mats used for the square-stepping exercise. 
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Figure 9: Pattern examples—Beginner, intermediate and advanced square-stepping patterns. 
 
Statistical Analysis 
Statistical analysis was completed using IBM SPSS software version 23 (SPSS Inc., 
Chicago, Il, USA). Statistical significance was set at p ≤ 0.05 and reported if it was met or 
was trending towards significance. Trending towards significance was characterized as 
(p=0.05-<0.10). Baseline characteristics were compared between groups with 
independent sample t-tests for outcome measures with normal distribution or Mann-
Whitney U tests for outcome measures that were not normally distributed. Non-
parametric tests were used for outcomes measures with gross violations of normality and 
homogeneity of variance (HRV parameters and GCF domains). Mann-Whitney U tests 
were selected to determine if there were differences in parameters between groups at 
baseline and at 24-weeks. Wilcoxon Signed Ranks tests were used to examine changes 
over time and were employed separately for the intervention and control groups. Outcome 
measures that did not violate assumptions (SBP and DBP), used independent sample t-
tests to examine differences between groups at each time point, and dependent sample t-
tests to examine the changes from baseline to 24-weeks for each group.  
The correlation of HRV and GCF was performed using the Spearman (rho). Differences 
between groups were also examined in mean change from baseline to 24-weeks. Outliers 
were assessed using studentized residuals greater than ±3 standard deviations and were 
removed prior to analysis. Estimates of effect sizes were calculated for t-tests (eta2), and  
i)
2 4 2 4
3 6 3 6
1 5 1 5
ii)
3 5 3 5 3 5 3 5
1 4 1 4 1 4 1 4
2 6 2 6 2 6 2 6
iii)
1 3 7 5 1 3 7 5
4 2 6 8 4 2 6 8
Finish Walk
Finish Walk
Finish Walk
Beginner Pattern—focused on walking-like movements and simple steps
Intermediate Pattern—incorporates forward, lateral and diagonal movements
Advanced Pattern—a large number of steps per pattern with multiple movement types
Start Walk
Start Walk
Start Walk
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Mann-Whitney U and Wilcoxon Signed Ranks tests, r = Z/√(N). All results are shown as 
mean ± (standard deviation; SD) for normally distributed data, and median (interquartile 
range; IQR) for non-parametric data.  
2.3 Results 
Participant Flow 
Recruitment took place between February 2015 and December 2015. Figure 10 shows the 
flow of participants through the study. A total of 36 potential participants were assessed 
for eligibility. 11 individuals were excluded from the study due to not meeting inclusion 
criteria [clinical depression (n=3); orthopedic limitation (n=1); absence of a cognitive 
complaint (n=1)] or declining to participate (n=6). A total of 25 participants were 
randomized into the current study and allocated into either the square-stepping 
intervention (n=12) or the wait-list control group (n=13). Throughout the 24-weeks, 4 
participants allocated to the square-stepping intervention group discontinued due to 
medical reasons (n=1) or personal reasons (n=3). There were no dropouts from the 
control group. HRV was not collected for 5 participants (HR monitors were unable to 
detect sinus rhythm). After removal of incomplete data, 19 participants were included in 
the final HRV analysis; 10 in the intervention and 9 in the control. 
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Figure 10: Participant Flowchart 
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Baseline Characteristics 
Participant baseline characteristics are located in Table 1 and presented as follows. 
Overall, 68.0% of participants were men, with a mean age of 68.7 years. 92.0% of 
participants were White and had an average education of 13.5 years. Average HR was 
72.2beats/min; average SBP was 134.0mmHg; and average DBP was 78.2mmHg. 
Participant global cognitive function averaged a mean score of 28.7 on the MMSE and 
25.6 on the MOCA. The average of total medications taken per person was 8.0. Out of all 
the participants who were taking medication, 88.0% were on diabetes medication, 80.0% 
were on hypertension medication and 84.0% were on cholesterol medication. There was a 
significant age difference between the intervention and control groups at baseline, t(23) = 
2.152, p = 0.042. 
Intervention Characteristics 
Attendance was recorded at all sessions, which was used to calculate compliance to the 
SSE intervention. Attendance was calculated as the percentage of classes attended (2 
classes per week) over the 24-week period. Session attendance for all waves of the SSE 
intervention group, excluding dropouts, was 52.2%.  
Follow-up of the study at 24-weeks was 66.7% for the participants in the SSE 
intervention group (4 out of 12 participants dropped out before final assessments), while 
follow-up in the wait-list control group was 100% (all 13 participants completed final 
assessments). 
In total, 7 participants (28.0%) experienced adverse events during the initial 24-week 
period of the square-stepping intervention. In the intervention group, a total of 10 adverse 
events were reported from 6 participants while the wait-list control group had one adverse 
event reported. Adverse events included back injuries (n=3), neck strain/headaches (n=1), 
knee injury (n=1), dizziness (n=1), bowel obstruction (n=1) and general pain/illness 
(n=4). Aside from the neck strain/headaches adverse event, all other adverse events were 
not caused by involvement in the current study. All participants recovered during the 
intervention period without further issues. 
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Table 1: Baseline participant characteristics— Values are reported as mean (SD) 
unless otherwise stated. 
Demographics All Participants 
(n=25) 
SSE Intervention 
Group (n=12) 
Wait-List 
Control Group 
(n=13) 
Age (years) 68.7 (6.6) 65.9 (5.2) 71.2 (6.9) * 
Male sex, no. (%) 17 (68.0) 8 (66.7) 9 (69.2) 
White race, no. (%) 23 (92.0) 10 (83.3) 13 (100) 
Education (years) 13.5 (2.3) 13.7 (2.5) 13.4 (2.1) 
Height (m) 1.7 (0.1) 1.7 (1.0) 1.7 (0.1) 
Weight (kg) 91.4 (15.8) 94.5 (19.6) 88.5 (11.4) 
BMI (kg/m2) 32.6 (4.7) 33.3 (4.8) 32.0 (4.6) 
WC (cm) 112.2 (12.2) 113.6 (15.4) 110.9 (8.9) 
HR (beats/min) 72.2 (11.2) 75.9 (6.8) 68.8 (13.4) 
SBP (mmHg) 134.0 (16.9) 131.7 (12.2) 136.5 (21.3) 
DBP (mmHg) 78.2 (8.6) 79.9 (6.2) 76.5 (10.5) 
CES-D (/60) 8.2 (7.8) 8.2 (8.4) 8.3 (7.5) 
MMSE (/30) 28.7 (1.1) 28.9 (0.9) 28.5 (1.2) 
MOCA (/30) 25.6 (2.7) 25.4 (2.7) 25.9 (2.7) 
GCF domains  
(z-scores), Md (IQR) 
   
     Memory 0.17 (1.34) 0.12 (1.47) 0.26 (1.38) 
     Concentration -0.12 (1.05) 0.01 (1.16) -0.21 (1.05) 
     Reasoning 0.03 (1.01) -0.02 (1.21) 0.03 (1.09) 
     Planning -0.02 (1.30) -0.10 (1.17) 0.06 (1.35) 
     GCF -0.02 (1.06) -0.06 (1.18) -0.02 (0.88) 
Total medication, per 
person 
8.0 (4.9) 7.0 (4.3) 9.0 (5.4) 
Types of medication, 
no. (%) 
   
     Diabetes 22 (88.0) 11 (91.7) 11 (84.6) 
     Hypertension 20 (80.0) 8 (66.7) 12 (92.3) 
     High cholesterol 21 (84.0) 9 (75.0) 12 (92.3) 
Medical history, no. 
(%) 
   
     Cardiac  9 (36.0) 5 (41.7) 4 (30.8) 
     Cancer  5 (20.0) 3 (25.0) 2 (15.4) 
*statistically significant difference between groups p≤0.05                                                                                       
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Outcome measures that were normally distributed used independent t-tests to determine if there were 
significant differences between groups at baseline.                                                                                   
Global cognitive function domains were not normally distributed, therefore Mann-Whitney U tests was 
used to determine if there were significant differences between groups at baseline (i.e. global cognitive 
function domains).                                                                                                                                          
Key: BMI, body mass index; WC, waist circumference; HR, heart rate; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; CES-D, center of epidemiologic studies depression scale; MMSE, mini mental 
state examination; MOCA, Montreal cognitive assessment; GCF, global cognitive function; Md, median; 
IQR, interquartile range 
 
Primary Outcome: Heart Rate Variability 
As previously reported in Table 1, there was a significant difference in age between the 
SSE intervention group and the WL control group. After removing the five participants 
who could not undergo HRV analysis, due to the HR monitor’s inability to detect sinus 
rhythm, age was no longer found to be significantly different between groups, t(18) = 
1.286, p = 0.215.  
No significant differences were found between groups at baseline and at 24-weeks, 
however HR in both the supine and standing positions were trending to be significantly 
higher in the SSE group compared to the WL group at baseline, U = 22.0, Z = -1.885, p = 
0.059, r = 0.43 and U = 21, Z = -1.729, p = 0.084, r = 0.41, respectively. No significant 
differences were found in mean change between groups. 
Results for changes in HRV parameters from baseline to 24-weeks for the supine, sitting 
and standing positions are shown in Table 2, Table 3 and Table 4 respectively. A 
Wilcoxon Signed Ranks test revealed a statistically significant reduction in standing HR 
in the SSE group over 24-weeks, Z = -1.997, p = 0.046, r = 0.50 (Figure 11). Significant 
reductions were also found in sitting LF (Figure 12) and HF (Figure 13) in the WL group 
over 24-weeks, Z = -1.960, p = 0.05, r = 0.48 and Z = -2.028, p = 0.043, r = 0.49, 
respectively. Although not significant, the following were trending towards significance: 
i) a reduction in supine LF/HF in the SSE group over 24-weeks, Z = -1.859, p = 0.063, r = 
0.45; ii) a reduction in sitting SDNN in the WL group over 24-weeks, Z = -1.859, p = 
0.063, r = 0.45; iii) and reductions in supine and sitting RMSSD in the WL group over 
24-weeks, Z = -1.690, p = 0.091, r = 0.44 and Z = -1.820, p = 0.069, r = 0.44, 
respectively.  
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Table 2: Changes in heart rate variability in the supine position from baseline to 24-
weeks— Values are reported as median (IQR). 
Variables Baseline 24-weeks Within 
Groups Δ P 
Between 
Groups Δ P 
HR (b/min)     
     SSE 76.0 (13.0) 72.0 (8.0) 0.734  
     WL 66.0 (17.0) 68.0 (21.0) 0.326  
     SSE vs. WL 0.059   0.709 
SDNN (ms)     
     SSE 23.0 (19.8) 20.0 (15.0) 0.249  
     WL 22.5 (29.5) 18.0 (12.3) 0.123  
     SSE vs. WL 0.929   0.524 
RMSSD (ms2)     
     SSE 147.5 (315.5) 133.0 (196.0) 0.310  
     WL 108.0 (213.0) 100.0 (57.5) 0.091  
     SSE vs. WL 0.495   0.949 
LF (ms2)     
     SSE 110.0 (251.8) 53.0 (249.0) 0.237  
     WL 76.0 (273.0) 64.5 (62.5) 0.176  
     SSE vs. WL 0.495   0.949 
HF (ms2)     
     SSE 50.0 (113.0) 56.0 (88.0) 0.310  
     WL 30.0 (34.0) 29.0 (31.3) 0.398  
     SSE vs. WL 0.464   0.789 
LF/HF     
     SSE 1.5 (4.2) 1.1 (2.1) 0.063  
     WL 1.2 (4.3) 2.2 (1.1) 0.767  
     SSE vs. WL 0.462   0.491 
Statistically significant p≤0.05 
Within groups Δ was calculated with the Wilcoxon Signed Ranks test. 
Between groups Δ was calculated with the Mann-Whitney U test. 
The difference between SSE vs. WL at baseline was calculated with the Mann-Whitney U test. 
Key: HR, heart rate; SDNN, normal-to-normal R-R intervals; RMSSD, root mean square of successive R-R 
interval differences; LF, low frequency; HF, high frequency; SSE, square-stepping exercise intervention; 
WL, wait-list control 
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Table 3: Changes in heart rate variability in the sitting position from baseline to 24-
weeks — Values are reported as median (IQR). 
Variables Baseline 24-weeks Within 
Groups Δ P 
Between 
Groups Δ P 
HR (b/min)     
     SSE 76.0 (8.5) 74.0 (7.0) 0.670  
     WL 67.0 (24.5) 67.0 (24.5) 0.767  
     SSE vs. WL 0.122   0.974 
SDNN (ms)     
     SSE 22.0 (10.5) 21.0 (7.0) 0.399  
     WL 23.5 (18.8) 17.0 (9.5) 0.063  
     SSE vs. WL 0.846   0.352 
RMSSD (ms2)     
     SSE 109.0 (309.5) 111.0 (169.0) 1.000  
     WL 126.5 (178.75) 86.0 (176.5) 0.069  
     SSE vs. WL 1.000   0.203 
LF (ms2)     
     SSE 124.0 (71.0) 73.0 (102.0) 0.866  
     WL 95.5 (116.8) 70.0 (46.5) 0.05  
     SSE vs. WL 0.962   0.165 
HF (ms2)     
     SSE 49.0 (134.0) 34.0 (96.0) 1.000  
     WL 41.5 (54.5) 27.0 (31.5) 0.043  
     SSE vs. WL 0.773   0.203 
LF/HF     
     SSE 1.4 (2.5) 1.4 (1.9) 0.612  
     WL 2.0 (3.2) 2.2 (2.5) 0.767  
     SSE vs. WL 0.825   0.427 
Statistically significant p≤0.05 
Within groups Δ was calculated with the Wilcoxon Signed Ranks test. 
Between groups Δ was calculated with the Mann-Whitney U test. 
The difference between SSE vs. WL at baseline was calculated with the Mann-Whitney U test. 
Key: HR, heart rate; SDNN, normal-to-normal R-R intervals; RMSSD, root mean square of successive R-R 
interval differences; LF, low frequency; HF, high frequency; SSE, square-stepping exercise intervention; 
WL, wait-list control 
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Table 4: Changes in heart rate variability in the standing position from baseline to 
24-weeks — Values are reported as median (IQR). 
Variables Baseline 24-weeks Within 
Groups Δ P 
Between 
Groups Δ P 
HR (b/min)     
     SSE 81.0 (10.0) 79.0 (7.0) 0.046  
     WL 70.0 (25.0) 73.0 (28.5) 0.813  
     SSE vs. WL 0.084   0.426 
SDNN (ms)     
     SSE 21.0 (6.5) 17.0 (7.0) 0.340  
     WL 23.0 (29.0) 15.0 (24.5) 0.213  
     SSE vs. WL 0.825   0.958 
RMSSD (ms2)     
     SSE 91.5 (94.8) 91.0 (130.0) 0.600  
     WL 75.0 (1443.8) 62.5 (89.0) 0.176  
     SSE vs. WL 0.674   0.153 
LF (ms2)     
     SSE 70.0 (72.0) 74.0 (48.0) 0.735  
     WL 61.0 (138.25) 40.5 (35.75) 0.208  
     SSE vs. WL 0.773   0.183 
HF (ms2)     
     SSE 47.0 (48.5) 31.0 (48.0) 0.917  
     WL 25.0 (84.8) 17.0 (18.8) 0.128  
     SSE vs. WL 0.736   0.277 
LF/HF     
     SSE 2.3 (4.9) 1.9 (1.6) 0.463  
     WL 2.3 (3.2) 2.4 (1.9) 0.859  
     SSE vs. WL 0.566   0.480 
Statistically significant p≤0.05 
Within groups Δ was calculated with the Wilcoxon Signed Ranks test. 
Between groups Δ was calculated with the Mann-Whitney U test. 
The difference between SSE vs. WL at baseline was calculated with the Mann-Whitney U test. 
Key: HR, heart rate; SDNN, normal-to-normal R-R intervals; RMSSD, root mean square of successive R-R 
interval differences; LF, low frequency; HF, high frequency; SSE, square-stepping exercise intervention; 
WL, wait-list control 
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Figure 11: Changes in heart rate in the standing position within groups at baseline and 24-weeks—
Values are reported as median (IQR); *statistically significant differences to baseline p≤0.05; HR, heart 
rate; WL, wait-list control; SSE, square-stepping exercise intervention 
 
 
Figure 12: Changes in low frequency in the sitting position within groups at baseline and 24-week—
Values are reported as median (IQR); *statistically significant differences to baseline p≤0.05; LF, low 
frequency; WL, wait-list control; SSE, square-stepping exercise intervention 
* 
* 
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Figure 13: Changes in high frequency in the sitting position within groups at baseline and 24-week—
Values are reported as median (IQR); *statistically significant differences to baseline p≤0.05; HF, high 
frequency; WL, wait-list control; SSE, square-stepping exercise intervention 
 
Secondary Outcome: Correlation between Heart Rate Variability and Global 
Cognitive Function 
A spearman correlation between HRV parameters (HR, RMSSD) and GCF showed no 
correlation for either group at baseline. At 24-weeks, there were large negative 
correlations in the WL group between RMSSD in both the sitting and standing positions 
versus GCF, rho = -0.70, p = 0.036, n = 9 and rho = -0.76, p = 0.031, n = 8, respectively. 
Therefore, as RMSSD decreased, GCF increased. The coefficient of determination of 
RMSSD in the sitting position was 49%, which suggest that 49% of variability in one 
variable can be predicted by the other. Likewise for the coefficient of determination of 
RMSSD in the standing position was 58%, which suggest that 58% of variability in one 
variable can be predicted by the other. Also in the WL group at 24-weeks, a large positive 
correlation between HR in the sitting position versus GCF was trending towards 
significance, rho = 0.61, p = 0.081, n = 9; as HR increased, so did GCF. No significant 
correlations were found in the SSE group between HRV parameters versus GCF. No 
significant differences in mean change were found. 
* 
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Tertiary Outcome: Resting Blood Pressure 
SBP and DBP did not differ statistically between groups at baseline or at 24-weeks. After 
running dependent sample t-tests for resting average BP, there was a significant decrease 
in the WL group for SBP from baseline (M = 138.1, SD = 21.7, n = 10) to 24-weeks (M = 
122.0, SD = 20.4, n = 10), t(9) = 2.896, p = 0.018 (Table 5). The mean decrease in SBP 
(Figure 14) was 16.1mmHg (95% confidence interval, CI; 3.5 to 28.7), with an eta2 (0.48) 
indicating a large effect size. Although not significant, DBP in the WL group was 
trending towards a significant decrease from baseline (M = 75.5, SD = 10.8, n = 10) to 
24-weeks (M = 69.7, SD = 11.3, n = 10), t(9) = 2.251, p = 0.051. The mean decrease in 
DBP was 5.8mmHg (95% CI -0.03 to 11.6), with an eta2 (0.46) indicating a large effect 
size. There were no significant changes for resting average SBP and DBP from baseline 
to 24-weeks in the SSE group. Although no significant differences were found, the mean 
change in SBP between groups was trending towards significance, p = 0.091.  
 
Table 5: Changes in systolic and diastolic blood pressure from baseline to 24-
weeks— Values are reported as means (SD). 
Variables Baseline 24-weeks Within 
Groups Δ P 
Between 
Groups Δ P 
SBP (mmHg)     
     SSE 135.9 (14.3) 131.3 (13.4) 0.184  
     WL 138.1(21.7) 122.0 (20.4) 0.018  
     SSE vs. WL 0.523   0.091 
DBP (mmHg)     
     SSE 81.3 (7.8) 77.6 (9.9) 0.197  
     WL 75.5 (10.8) 69.7 (11.3) 0.051  
     SSE vs. WL 0.346   0.575 
Statistically significant p≤0.05 
Within groups Δ was calculated with dependent sample t-tests. 
Between groups Δ was calculated with independent sample t-tests. 
The difference between SSE vs. WL at baseline was calculated with independent sample t-tests. 
Key: SBP, systolic blood pressure; DBP, diastolic blood pressure; SSE, square-stepping exercise 
intervention; WL, wait-list control 
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Figure 14: Changes in systolic blood pressure within groups at baseline and 24-week—Values are 
reported as mean (SD); *statistically significant differences to baseline p≤0.05; SBP, systolic blood 
pressure; WL, wait-list control; SSE, square-stepping exercise intervention 
 
2.4 Discussion 
The primary research question was to elucidate whether a square-stepping exercise 
intervention could positively influence autonomic function, as measured by improved 
HRV, in older T2D adults. Five prominent and novel findings emerged from this study: 1) 
HR was significantly reduced in the standing position for the SSE group at 24-weeks 
compared to baseline; 2) LF was significantly reduced in the sitting position for the WL 
group at 24-weeks compared to baseline; 3) HF was significantly reduced in the sitting 
position for the WL group at 24-weeks compared to baseline; 4) there were large 
significant negative correlations between RMSSD in the sitting and standing positions 
versus GCF in the WL group at 24-weeks; and 5) resting SBP was significantly lower at 
24-weeks compared to baseline in the WL group. Such findings are noteworthy because it 
is unclear as to why predominant vagal modulation was found in both the intervention 
and control. 
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Although studies examining the effects of exercise interventions on HRV in T2D are 
mixed, it was hypothesized that following SSE training there would be a shift towards 
vagal dominance (Sandercock et al., 2005); parameters representing predominant vagal 
modulation would increase (HF and RMSSD) and parameters representing sympathetic 
modulation (HR, SDNN, LF and LF/HF) would decrease (Tulppo et al., 2003). These 
shifts towards vagal dominance were predicted to only be observed in positions requiring 
greater BRS activation, such as sitting and standing (Michel-Chávez et al., 2015). 
Additionally, it was hypothesized that both SBP and DBP would be reduced following 
SSE training (Figueira et al., 2014). This investigation showed changes in HRV 
parameters and BP following SSE training that were unexpected. 
Autonomic Responses during Postural Changes  
In the literature, exercise training lowers SNS activation, increases BRS and improves 
glycemic control in T2D (Loimaala et al., 2003). Following aerobic exercise, the 
autonomic balance is shifted towards vagal modulation and away from SNS modulation, 
thus improving HRV. Postural changes from supine to sit and stand still elicit SNS 
activation to compensate for the physical challenges imposed by gravity however, BP is 
stabilized faster and HRV parameters are stabilized back to a more vagally modulated 
homeostatic “set point” (Finucane et al., 2014; Zhang, 2007). In the current study, 
significant shifts towards vagal modulation were observed in the sitting and standing 
positions—resulting in improved HRV (increased HF and reduced LF and HR). 
Improvements in HRV may not have been observed in supine due to a lack of SNS 
modulation and baroreflex activation required for that position. These findings are 
consistent with the literature, as shifts towards vagal modulation have only been observed 
in positions that required greater SNS stimulation with corresponding vagal withdrawal 
(Hnatkova et al., 2013) 
A Shift towards Vagal Modulation 
No statistical interaction was discovered between groups at 24-weeks for any HRV 
parameter, however, a significant decrease in HR was observed in the SSE intervention 
group following 24-weeks of SSE training. This observation is in line with both our 
hypothesis and the literature. HR has been considered a crude measure of autonomic 
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imbalance, and numerous studies have shown that a higher resting HR is associated with 
increased mortality and morbidity (Koenig et al., 2016). It has been suggested that aerobic 
exercise protects the heart against harmful cardiac events by increasing vagal tone and 
decreasing SNS activity (Hautala et al., 2004). Our findings suggest that the shift towards 
vagal dominance, as demonstrated by reduced HR, may also apply to cognitive exercises.  
HRV parameters considered reflective of vagal activity under resting conditions (RMSSD 
and HF) showed no significant change from baseline to 24-weeks in the SSE group for 
the current study. A meta-analysis on the effects of exercise in HRV by Sandercock et al 
(2005) concluded that the change in HF power due to exercise training was 
homogenously increased across all studies. There were no significant changes in HF for 
any of the postures in the SSE intervention group; however, a significant decrease in HF 
was found in the WL group. Therefore, one could argue that following 24-weeks of SSE 
training, the SSE group maintained HF power while the WL group showed significant 
reductions. The ability of the SSE group to maintain HF is indicative of a shift towards 
vagal modulation and improved HRV. Interestingly, Sandercock et al (2005) also 
demonstrated that old and middle-aged subjects showed small and moderate effect sizes 
of improved HF, respectively. This may suggest a reduced trainability of the heart and 
associated neural input with age. A reduced trainability in older adults may explain why 
HF power was maintained, rather than improved—especially given the older population 
recruited for the current study (54 to 82 years). Moreover, the meta-analysis excluded 
studies with disease populations, therefore omitting T2D populations in which trainability 
may further be reduced (Sandercock et al., 2005). 
Furthermore, in a study by Zoppini et al (2007) examining HRV in the supine and 
standing positions following a 6 month supervised aerobic exercise in sedentary T2D 
adults, HF was found to be significantly increased and LF significantly decreased 
following exercise in the standing position. No significant results were found in the 
supine position. They concluded that the LF/HF ratio, which is reflective of 
sympathovagal balance, was markedly decreased after exercise (Zoppini et al., 2007). 
These results are in line with the current study, where LF was decreased and HF was 
increased in the sitting position after 24-weeks. However, contrary to the hypothesis 
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stating that the shift towards vagal modulation would be seen in the SSE intervention 
group, it was observed in the WL control group at 24-weeks.  
Correlation between Heart Rate Variability and Global Cognitive Function 
Though the associations between HRV and GCF following cognitive exercise training in 
a diabetic population has never before been studied, a recent meta-analysis on 
perseverative cognition (the rumination about the past and worries about the future) in 
healthy subjects by Ottaviani et al (2015) may provide insight into the effects of HRV on 
cognitive health. To reiterate, a subjective cognitive complaint is the belief that one’s 
thinking and/or memory has gotten worse recently. Worrying about worsening memory or 
cognition may further increase the risk for dementia in the T2D population (Xu et al., 
2010). Analysis of eight studies showed an association between perseverative cognition 
and decreased HRV (Ottaviani et al., 2015). Although the meta-analysis did not divulge 
which HRV parameters were decreased, the negative correlation between perseverative 
cognition and HRV are in line with the findings of the current study, and may explain the 
significant correlation between reduced RMSSD and improved GCF. Further research is 
require to investigate the relationship between HRV parameters and cognition in disease 
populations. 
Resting Blood Pressure 
Historically, aerobic exercise training has been shown to reduce both SBP and DBP in 
T2D individuals (Figueira et al., 2014). Additionally, reductions in BP are known to be 
additive in reducing the chronic complications of T2D (Figueira et al., 2014). A meta-
analysis by Cornelissen & Fagard (2005) examined resting BP and its regulating 
mechanisms in RCTs. In individual studies, the average net changes following aerobic 
exercise in resting BP ranged from -20.0 to +9.0mmHg for SBP and -11.0 to +11.3mmHg 
for DBP. The overall net effect on BP was -3.0/-2.4mmHg, with the greatest effect 
observed in hypertensive individuals (Cornelissen & Fagard, 2005; Figueira et al., 2014).  
Similarly, results from the current study showed significant reductions in SBP from 
baseline to 24-weeks, while DBP trended towards significance (p = 0.051). The 
reductions in resting SBP and DBP for the current study, -16.1mmHg and -5.8mmHg 
respectively, fall within the range reported in the literature. Although these reductions in 
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BP were expected at 24-weeks, it was hypothesized that the SSE intervention group 
would experience this shift towards vagal modulation, not the WL control group. One 
possible explanation that may account for the aforementioned findings are medications 
blunting BP responses. 
Medications Blunting Heart Rate Variability and Blood Pressure Responses 
Beta-blockers have been shown to improve HRV and are associated with a better 
prognosis following an MI (Malfatto et al., 1996). Airaksinen et al (1994) observed the 
effects of metoprolol and atenolol on stable CAD patients compared to a placebo group. 
They found that beta-blockers induced a shift towards vagal modulation by increasing 
PNS activation (higher HF) and reducing sympathetic activation (lower LF), thus 
improving HRV in CAD patients (Airaksinen et al., 1994). In the current study, 80.0% of 
all participants were on BP lowering medication at baseline— 92.3% of participants on 
hypertensive medication were in the WL group and 66.7% were in the SSE group. Upon 
completion of the study, medications for all participants remained the same. Considering 
that more participants in the WL were on hypertensive medication, the improvements in 
HRV, as demonstrated by reduced LF and BP, may be attributed to the medication 
responses.  
T2D medications have also been shown to cause hypoglycemic events and alter HRV 
responses. Since 91.7% of participants in the SSE group and 84.6% of participants in the 
WL group were on at least one, or a combination of T2D medications, examining the 
effect of medications on HRV is appropriate. A study by Soydan et al (2013) 
demonstrated that the combination of glibenclamide (T2D medication) and exercise 
increased the number of hypoglycemic events by 33% when compared to glibenclamide 
alone, and 83% when compared to exercise alone. Results revealed that the mild 
hypoglycemia, caused by T2D medication, resulted in significant decreases of cardiac 
vagal outflow and HRV (SDNN, RMSSD, TP, HF and VLF). Researchers concluded that 
the HRV response to hypoglycemia is impaired in T2D patients, causing a higher than 
expected risk for cardiac arrhythmia following mild hypoglycemic episodes (Soyden et 
al., 2013).  
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Consequently, as medications may have caused reductions in LF and BP in the WL 
group, participants in the SSE group may also have reached their capacity for maximal 
autonomic improvements by way of medication. Therefore, the lack of improvement in 
RMSSD and HF may be due to medications blunting HRV responses, and not as the 
result of cognitive exercise training. 
The Square-Stepping Exercise 
The SSE is a low-intensity novel exercise originally targeted as a fall prevention strategy 
in the elderly (Shigematsu & Okura, 2006). Recently it has been utilized as a cognitive 
exercise intervention to assist with GCF in older adults with subjective cognitive 
complaints (Gill et al., 2016; Teixeira et al., 2013). SSE has never been implemented in a 
diabetic population before. It was hypothesized that people with T2D, who are known to 
develop autonomic dysfunction and be at greater risk of cognitive decline, would improve 
both their HRV and GCF following a SSE program. However, results from the current 
study are peculiar and demonstrate improvement in HRV parameters for both the SSE 
and WL groups. Frequency and intensity of training may be important factors as to why 
there were no significant improvements in RMSSD and HF for the SSE group. In the 
literature, research studies with five to six exercise training sessions per week showed 
improvements in HRV, while less than four per week had mixed findings (Stuckey, 
2013). Exercise interventions were also generally performed at a moderate- to high-
intensity (Hautala et al., 2004; Tulppo et al., 2003; Cassilhas et al., 2007). Duration of 
exercise was not found to affect HRV modifications towards vagal dominance (Stuckey, 
2013). Because SSE is such a novel exercise, there are currently no recommended 
exercise guidelines associated with it, therefore we created our own; 45 minute sessions, 
2 times per week. It is likely that the low-intensity and low-frequency aspect of the SSE, 
which was suitable for our older diabetic population, was inadequate to invoke autonomic 
changes. It is possible that increasing the frequency and perhaps intensity of the SSE may 
improve HRV. However, if frequency and intensity are increased, the SSE may no longer 
be suitable for our target population.  
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Sample Size and Attendance 
Other reasons concerning the lack of effect could possibly be attributed to sample size 
(i.e. lack of statistical power). Regardless of the amount of time spent recruiting for this 
study, sample size remained low. This could be attributed to factors such as the duration 
of the intervention and our population of interest. The intervention period was 24-weeks, 
which is a substantial amount of time to commit to 75% of the session (exclusion from 
the study if the participant did not believe they could meet that requirement). The first 
wave of the intervention was to commence in the summer of 2015. Some potential 
participants were dissuaded from the study because of vacation plans or conflicting 
schedules on the days of the SSE classes.  
The population under investigation was a very specific and relatively small population. 
Participants were required to have stable T2D, be 50 years or older and have a self-
reported cognitive complaint. While recruiting, participants may have had stable T2D, 
however they may also have had other comorbidities which prevented inclusion (i.e. 
mobility issues) or prevented them from wanting to participate (i.e. constant pain). With 
regards to the cognitive criteria, some people either did not want to admit they had 
memory and/or thinking problem or they were not concerned about them, and therefore 
could not be included in the study. Another paradoxical issue when working with 
cognitively impaired subjects is that sometimes participants forgot about important 
assessments, regardless of reminders the day before. On occasion, this led to incomplete 
data. 
As previously mentioned, the overall attendance for the SSE intervention group was 
52.2%. Efforts to maintain adherence to the exercise program were made, however 
attendance to the SSE classes remained poor. Not only were all the dropouts for our study 
in the intervention group (n = 4), but the remainder of the participants only attended on 
average 50% of the sessions. It is not surprising that only HR in the standing position was 
found to be significantly reduced in the SSE group at 24-weeks. The participants with the 
lowest levels of attendance often: 1) had more medical issues; 2) had work that conflicted 
with the classes; or 3) simply did not wish to attend. Seasonal effects may have also 
played a role in SSE class attendance. During the winter months, participants may have 
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been dissuaded to attend the classes due to unsafe driving conditions. Likewise in the 
summer, many participants had to care for grandchildren who were on summer break and 
therefore were unable to attend some classes. 
Limitations and Future Research 
This novel study has developed knowledge on the effects of a cognitive exercise on HRV 
parameters. The current study was not without limitations; however it may provide future 
study directions that could help elucidate the nature of cognitive decline and develop 
preventative interventions for autonomic dysfunction. Firstly, it should be recognized that 
the current study was a pilot-study conducted to evaluate the feasibility of examining 
HRV in older T2D adults following the implementation of a mind-motor exercise 
program. Consequently, a major limitation is that the sample size remained small, 
regardless of multiple recruitment strategies. A larger sample size may have shown 
further increases in vagal modulation in the SSE group following the intervention. Due to 
our specific population, the HR monitors had a difficult time picking up sinus rhythm and 
participants were more likely to experience ectopic beats/irregularities in the ECG 
recordings. Thus rendering the data unanalyzable for five participants. HRV assessments 
were also done at different times of day. Therefore, there may be other factors apart from 
the SSE affecting HRV, such as lack of sleep, physiological stressors, caffeine, large 
meals, excessive exercise, and alcohol. Future studies may focus on keeping HRV 
assessments at a consistent time of day and controlling for food and caffeine intake before 
assessments. An older population was recruited for the current study. Some individuals 
were not familiar with computers and/or did not know how to properly work the mouse 
while playing the CBS games. Therefore, their scores may not necessarily be a reflection 
of their cognitive function, but their inability to use the equipment. Finally, future studies 
should also administer questionnaires regarding daily exercise, food and medication to 
both the SSE and WL groups to confirm that their daily habits do not change throughout 
the intervention period; as done in a study by Kitazawa et al (2015). 
Despite these limitations, the current study holds promise in elucidating the effects of a 
mind-motor exercise in aging and disease populations. Therefore, larger studies 
examining HRV responses to recommended exercise guidelines in T2D populations are 
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warranted. Future studies could investigate the effects of increased SSE training 
frequency or the combination of aerobic and cognitive training on HRV parameters as 
well as focusing on maintaining breathing frequency during HRV assessments. Lastly, a 
follow-up assessment for the WL group after completion of the SSE training (at 48-
weeks) may be used to determine if the changes in the WL group are consistent with the 
changes observed in the SSE group following the intervention.  
2.5 Conclusion 
In conclusion, the implementation of a 24-week SSE program revealed a shift towards 
vagal modulation in both the intervention and control groups for T2D individuals with 
subjective cognitive complaints. It is unclear as to why this shift in vagal modulation was 
observed in the control group, however, medication and sample size may have played an 
influential role. Although there is promise, the overall finding of the current pilot-study 
remains inconclusive. It is crucial to understand the role of the ANS in HRV and how it 
may be accelerated with aging, disease and cognitive impairment; especially since these 
populations are on the rise. Examining the effects of cognitive exercises on HRV may 
provide invaluable insight into this relationship, therefore, additional research is required. 
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Appendix D: Breakdown of square-stepping patterns 
 
Levels 
 
Sublevels Number of Patterns 
Beginner 1 1-8 
2 1-30 
Intermediate 1 1-24 
2 1-30 
3 1-28 
Advanced 1 1-36 
2 1-14 
3 1-26 
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